glp 1 drugs pcos GLP‑1 GLP-1 therapy is changing the

Notably, this treatment increased the proportion of M1 macrophages expressing IL12 and IFN, leading to a more immunostimulatory tumor microenvironment ( Given the intratumoral heterogeneity of TAM polarization in ovarian cancer, a strategic combination of macrophage-targeted therapies, such as CSF1R and TREM2 inhibitors, with immunotherapies holds promise for improving clinical outcomes

Low glutathione levels have been linked to oxidative stress which may play a role in conditions such as cardiovascular disease and inflammatory bowel disease

Frequently referred to as the master antioxidant, glutathione functions not merely as a free radical scavenger but as a principal mediator of cellular detoxification

GA has been shown to halt cancer cell cycles at the S or G2/M phase, thereby suppressing proliferation (149)